文献速递艾滋病与性传播感染细菌感染、耐药与抗菌药物

人型支原体与非妊娠女性生殖道症状相关而脲原体无关

Are Mycoplasma hominis, Ureaplasma urealyticum and Ureaplasma parvum Associated With Specific Genital Symptoms and Clinical Signs in Nonpregnant Women?
PubMed 文献 · Clin Infect Dis · 2021-01-01

该研究纳入1272例非妊娠女性,采用问卷、检查和多重PCR检测人型支原体、解脲脲原体及微小脲原体。调整STI和VVC后,仅人型支原体与异常阴道分泌物、异味、pH>4.5及线索细胞相关,且这些表现属细菌性阴道病;无BV时无关联。不支持常规检测这三种支原体。

要点

  • 仅人型支原体与阴道分泌物、异味等细菌性阴道病表现相关。
  • 解脲脲原体和微小脲原体与症状/体征无关联。
  • 无细菌性阴道病时人型支原体也无症状关联,不支持常规检测。

核心结论

  • 仅人型支原体与症状/体征相关,且为细菌性阴道病表现;无BV时无关联。
  • 研究结果不支持对非妊娠女性常规检测人型支原体、解脲脲原体和微小脲原体。

研究设计与样本

  • 研究纳入1272例就诊于墨尔本性健康中心的非妊娠女性,填写问卷并接受检查。
  • 对有症状者行检查,评估细菌性阴道病和外阴阴道念珠菌病,并用商业多重PCR检测三种支原体及4种非病毒性STI。

主要发现

  • 调整STI和VVC后,人型支原体与异常阴道分泌物相关(aOR=2.70,95%CI:1.92-3.79)。
  • 人型支原体与阴道异味相关(aOR=4.27,95%CI:3.08-5.91),与阴道pH>4.5相关(aOR=4.27,95%CI:3.22-5.66),与线索细胞相关(aOR=8.08,95%CI:5.68-11.48)。
  • 脲原体属与症状/体征无关联;细菌性阴道病与人型支原体强相关(aOR=8.01,95%CI:5.99-10.71),与脲原体属无关联。
  • 分层分析中,人型支原体在BV女性中与自报阴道异味和医生记录的阴道分泌物相关,无BV女性中无关联。

临床怎么用

  • 对非妊娠女性出现阴道分泌物或异味时,应优先评估细菌性阴道病而非检测支原体。
  • 不推荐将人型支原体、解脲脲原体和微小脲原体作为非妊娠女性常规STI检测项目。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is limited evidence supporting an association between Mycoplasma hominis, Ureaplasma urealyticum, and Ureaplasma parvum with symptoms or disease in nonpregnant women. However, testing and reporting of these organisms frequently occurs, in part due to their inclusion in multiplex-PCR assays for sexually transmitted infection (STI) detection. We investigated if M. hominis, U. urealyticum, and U. parvum were associated with symptoms and/or signs in nonpregnant women attending a sexual health service. METHODS: Eligible women attending the Melbourne Sexual Health Centre completed a questionnaire regarding sexual practices and symptoms. Symptomatic women underwent examination. Women were assessed for bacterial vaginosis (BV) and vulvovaginal candidiasis (VVC), and tested for M. hominis, U. urealyticum, and U. parvum, and 4 nonviral STIs using a commercial multiplex-PCR. RESULTS: 1272 women were analyzed. After adjusting for STIs and VVC, M. hominis was associated with abnormal vaginal discharge (aOR = 2.70, 95%CI:1.92-3.79), vaginal malodor (aOR = 4.27, 95%CI:3.08-5.91), vaginal pH > 4.5 (aOR = 4.27, 95%CI:3.22-5.66), and presence of clue cells (aOR = 8.08, 95%CI:5.68-11.48). Ureaplasma spp. were not associated with symptoms/signs. Bacterial vaginosis was strongly associated with M. hominis (aOR = 8.01, 95%CI:5.99-10.71), but was not associated with either Ureaplasma spp. In stratified analyses, M. hominis was associated with self-reported vaginal malodor and clinician-recorded vaginal discharge in women with BV, but not with symptoms/signs in women without BV. CONCLUSIONS: Only M. hominis was associated with symptoms/signs, and these were manifestations of BV. Importantly, M. hominis was not associated with symptoms/signs in women without BV. These findings do not support routine testing for M. hominis, U. urealyticum, and U. parvum in nonpregnant women.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Plummer EL, Vodstrcil LA, Bodiyabadu K, et al. Are Mycoplasma hominis, Ureaplasma urealyticum and Ureaplasma parvum Associated With Specific Genital Symptoms and Clinical Signs in Nonpregnant Women? Clin Infect Dis. 2021. PMID: 33502501. doi:10.1093/cid/ciab061

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。